QCLS

TNF Pharmaceuticals, Inc. Common Stock QCLS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode QCLS OST IFBD RVYL JTAI IOTR VEEA BNZI FTFT PRSO
6M 12.56 % -95.94 % 2.88 % -67.56 % -27.65 % -66.67 % -54.06 % -70.75 % 53.73 % 149.22 %
YTD 12.56 % -97.06 % -54.66 % -75.67 % -38.46 % -91.66 % -80.55 % -81.23 % -34.19 % 66.04 %
1Y 12.56 % -98.24 % -44.56 % -85.40 % -87.92 % -91.66 % -82.54 % -91.21 % -39.41 % 0.57 %
3Y 12.56 % -99.34 % -99.89 % -96.91 % -99.88 % -91.66 % -93.27 % -99.94 % -90.89 % -97.22 %
5Y 12.56 % -99.98 % -100.00 % -98.66 % -99.87 % -91.66 % -93.27 % -99.94 % -98.28 % -97.50 %
10Y 12.56 % -99.98 % -100.00 % -92.35 % -99.87 % -91.66 % -93.27 % -99.94 % -99.53 % -99.99 %
From the beginning 12.56 % -99.98 % -100.00 % -95.54 % -99.87 % -91.66 % -93.27 % -99.94 % -100.00 % -100.00 %

Dividend